New Enterprise Associates 16, L.P. 13D and 13G filings for Marker Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-26 10:38 am Purchase | 2021-03-16 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16, L.P. | 1,446,429 17.400% | 1,446,429 (New Position) | Filing |